In Vivo Metabolite Profiles of a GalNAc Conjugated Antisense Oligonucleotide AZD8233 Using Liquid Chromatography-High Resolution Mass Spectrometry: a Cross Species Comparison in Animals and Humans
AZD8233, a liver-targeting antisense oligonucleotide (ASO), inhibits subtilisin/kexin type 9 protein synthesis. It is a phosphorothioated 3-10-3 gapmer with a central DNA sequence flanked by constrained 2'- -ethyl 2',4'-bridged nucleic acid (cEt-BNA) wings and conjugated to a trianten...
Saved in:
Published in | Drug metabolism and disposition |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
10.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!